4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 25c
Tweet
Share
E-mailGet Alerts FDMT Hot Sheet
Join SI Premium – FREE
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) reported Q2 EPS of ($0.98), $0.25 worse than the analyst estimate of ($0.73).
For earnings history and earnings-related data on 4D Molecular Therapeutics, Inc. (FDMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA Committee Recommends To Widen Access To Bpc-157 Peptide
- Ameriprise Financial (AMP) Tops Q2 EPS by 29c
- Esquire Financial Holdings, Inc. (ESQ) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
